Shuanglu Pharmaceutical (002038) is the first high-tech enterprise in the capital to be listed on the Shenzhen Stock Exchange. Since its establishment in 1994, leveraging its technological advantages and continuous innovation, the company has researched, developed, and marketed over 70 varieties, including 3 national Class I new drugs with independent intellectual property rights. It has won one second prize of the National Science and Technology Progress Award and nine first, second, and third prizes of the Beijing Science and Technology Progress Award. The company closely aligns its product research and development with changes in the disease spectrum, maintaining a rich product pipeline in the fields of hematology, oncology, cardiovascular and cerebrovascular diseases, liver diseases, diabetes, and kidney disease treatment. The company has independently applied for and received funding from the National "863" Program four times. The company and Chairman Xu Mingbo have been awarded the "Outstanding Contribution Award" for the 20th anniversary of Zhongguancun's innovation and development.
The company currently has three R&D centers (in Beijing, the United States, and Canada) and five production bases (Badachu Production Base, Changping Production Base, Daxing Production Base, and Xinxiang API Production Base), with a total area of 150,000 square meters. Its production capacity covers high-tech fields involved in new pharmaceutical engineering, such as biological fermentation, biochemical, traditional Chinese medicine extraction, chemical APIs, and antibodies, as well as production lines for oral solid dosage forms, injections, powder injections, external preparations, and anti-tumor drugs, all built strictly in accordance with international GMP standards. The company has been listed among the top pharmaceutical suppliers in China for many years. Currently, the company has become a backbone enterprise in domestic biopharmaceuticals and a steadily growing biopharmaceutical company in the market.
What does Beijing Shuanglu Pharmaceutical Co., Ltd. require? Who is Shuanglu Pharmaceutical hiring? Shuanglu Pharmaceutical recruitment: 生物/制药/化工/环保类占比最多占42.2%，其次是技工类占40%. What education can get in at Shuanglu Pharmaceutical? 本科占比最多占57.8%，其次是大专占24.4%. High education required at Shuanglu Pharmaceutical? 硕士占2.2%. Work experience required at Shuanglu Pharmaceutical? 1-3年占比最多占53.3%，其次是3-5年占26.7%. Where are the job locations at Shuanglu Pharmaceutical? 北京占比最多占91.1%，其次是新乡占8.9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
